2-cyclopropyl-7-hydroxy-1H-benzo[d]imidazole-4-carboxylic acid | 1207429-69-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-cyclopropyl-7-hydroxy-1H-benzo[d]imidazole-4-carboxylic acid
• 英文别名: 2-cyclopropyl-7-hydroxy-1H-benzimidazole-4-carboxylic acid
• CAS: 1207429-69-3
• 化学式: C₁₁H₁₀N₂O₃
• 分子量: 218.212
• InChiKey: ANXCBFTZWJXBSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  86.2
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  甲醇 、 2-cyclopropyl-7-hydroxy-1H-benzo[d]imidazole-4-carboxylic acid 在 硫酸 作用下， 生成 methyl 2-cyclopropyl-7-hydroxy-1H-benzimidazole-4-carboxylate
  参考文献：
  名称：

  Structure–activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3β inhibitor

  摘要：

  Design, synthesis and the GSK3 beta inhibitory activities of the 7-hydroxy benzimidazole analogs are described. The solid-phase synthetic route was also developed for preparation of the analogs consisting of the novel ATP competitive scaffold. In addition, the structure-activity relationship of the 7-hydroxy benzimidazole analogs and their biological activities are reported. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.065
• 作为产物：
  描述：

  3-氨基-4-甲氧基苯甲酸 在 盐酸 、 aluminum (III) chloride 、 硫酸 、 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 生成 2-cyclopropyl-7-hydroxy-1H-benzo[d]imidazole-4-carboxylic acid
  参考文献：
  名称：

  Structure–activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3β inhibitor

  摘要：

  Design, synthesis and the GSK3 beta inhibitory activities of the 7-hydroxy benzimidazole analogs are described. The solid-phase synthetic route was also developed for preparation of the analogs consisting of the novel ATP competitive scaffold. In addition, the structure-activity relationship of the 7-hydroxy benzimidazole analogs and their biological activities are reported. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.065

文献信息

• [EN] 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES AND PBK INHIBITORS CONTAINING THE SAME<br/>[FR] DÉRIVÉS DE 7-HYDROXY-BENZO-IMIDAZOLE-4-YL-MÉTHANONE ET INHIBITEURS DE PBK LES CONTENANT
  申请人：ONCOTHERAPY SCIENCE INC

  公开号：WO2010051085A1

  公开（公告）日：2010-05-06

  7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives, which are useful for PBK inhibitors, are provided.

  7-羟基苯并咪唑-4-基甲酮衍生物，用于PBK抑制剂。
• [EN] BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE ET INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE-3-BÊTA CONTENANT CEUX-CI
  申请人：ONCOTHERAPY SCIENCE INC

  公开号：WO2010014794A1

  公开（公告）日：2010-02-04

  Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.

  苯并咪唑衍生物已提供。本发明的化合物对于糖原合成酶激酶-3β抑制剂是有用的。
• [EN] GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES<br/>[FR] INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE-3 BÊTA CONTENANT DES DÉRIVÉS DE 7-HYDROXY-BENZOIMIDAZOL-4-YL-MÉTHANONE
  申请人：ONCOTHERAPY SCIENCE INC

  公开号：WO2010058512A1

  公开（公告）日：2010-05-27

  GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula (I).

  提供了包括7-羟基苯并咪唑-4-基甲酮衍生物的GSK-3beta抑制剂。例如，这些抑制剂具有以下一般公式（I）。
• Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same
  申请人：Ohtani Mitsuaki

  公开号：US20110190351A1

  公开（公告）日：2011-08-04

  Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.

  本发明提供苯并咪唑衍生物。本发明的化合物可用作糖原合成酶激酶-3β抑制剂。
• GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES
  申请人：Matsuo Yo

  公开号：US20110301146A1

  公开（公告）日：2011-12-08

  GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula (I).

  提供了包含7-羟基苯并咪唑-4-基甲酮衍生物的GSK-3beta抑制剂。例如，抑制剂具有以下通式（I）。